T1	Participants 65 108	161 recurrence-free breast cancer patients.
T2	Participants 230 328	breast cancer patients, treated according to the Danish Breast Cancer Cooperative Group protocols.
T3	Participants 351 532	One hundred and sixty-one recurrence-free breast cancer patients were examined for radiation-induced brachial plexopathy after a median follow-up period of 50 months (13-99 months).
T4	Participants 584 602	high-risk patients
T5	Participants 1539 1555	younger patients
